Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia

Histone deacetylases (HDACs) are a key component of the epigenetic machinery regulating gene expression, and behave as oncogenes in several cancer types, spurring the development of HDAC inhibitors (HDACi) as anticancer drugs. This review discusses new results regarding the role of HDACs in cancer a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceccacci, Elena, Minucci, Saverio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800301/
https://www.ncbi.nlm.nih.gov/pubmed/26908329
http://dx.doi.org/10.1038/bjc.2016.36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800301/
https://www.ncbi.nlm.nih.gov/pubmed/26908329
http://dx.doi.org/10.1038/bjc.2016.36

Ejemplares similares